Lee Ashendorf1,2, Michael L Alosco3,4, Hanaan Bing-Canar3, Kimberly R Chapman3, Brett Martin3,5, Christine E Chaisson3,5,6, Diane Dixon3,5, Eric G Steinberg3, Yorghos Tripodis3,6, Neil W Kowall3,4,7,8, Robert A Stern3,4,9. 1. Department of Psychiatry, Boston University School of Medicine, Boston, Massachusetts, USA. 2. Edith Nourse Rogers Memorial Veterans Hospital, Bedford, Massachusetts, USA. 3. Boston University Alzheimer's Disease and CTE Center, Boston University School of Medicine, Boston, Massachusetts, USA. 4. Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, USA. 5. Data Coordinating Center, Boston University School of Public Health, Boston, Massachusetts, USA. 6. Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA. 7. Department of Pathology, Boston University School of Medicine, Boston, Massachusetts, USA. 8. Neurology Service, VA Boston Healthcare System, Boston, Massachusetts, USA. 9. Departments of Neurosurgery, and Anatomy & Neurobiology, Boston University School of Medicine, Boston, Massachusetts, USA.
Abstract
OBJECTIVE: Neuropsychological test performance can provide insight into functional abilities in patients with dementia, particularly in the absence of an informant. The relationship between neuropsychological measures and instrumental activities of daily living (IADLs) is unclear due to hetereogeneity in cognitive domains assessed and neuropsychological tests administered. Practical and ecologically valid performance-based measures of IADLs are also limited. The Neuropsychological Assessment Battery (NAB) is uniquely positioned to provide a dual-purpose assessment of cognitive and IADL function, as it includes Daily Living tests that simulate real-world functional tasks. We examined the utility of select NAB tests in predicting informant-reported IADLs in mild cognitive impairment and dementia. METHODS: The sample of 327 participants included 128 normal controls, 97 individuals with mild cognitive impairment, and 102 individuals with Alzheimer's disease dementia from the Boston University Alzheimer's Disease Center research registry. Informants completed the Lawton Brody Instrumental Activities of Daily Living Scale, and study participants were administered selected NAB tests that were complementary to the existing protocol. RESULTS: ROC curves showed strongest prediction of IADL (AUC > 0.90) for memory measures (List Learning delayed recall and Daily Living Memory delayed recall) and Daily Living Driving Scenes. At a predetermined level of specificity (95%), List Learning delayed recall (71%) and Daily Living Memory delayed recall (88%) were the most sensitive. The Daily Living Memory and Driving Scenes tests strongly predicted IADL status, and the other Daily Living tests contributed unique variance. CONCLUSIONS: NAB memory measures and Daily Living Tests may have clinical utility in detecting informant-rated functional impairment in dementia.
OBJECTIVE: Neuropsychological test performance can provide insight into functional abilities in patients with dementia, particularly in the absence of an informant. The relationship between neuropsychological measures and instrumental activities of daily living (IADLs) is unclear due to hetereogeneity in cognitive domains assessed and neuropsychological tests administered. Practical and ecologically valid performance-based measures of IADLs are also limited. The Neuropsychological Assessment Battery (NAB) is uniquely positioned to provide a dual-purpose assessment of cognitive and IADL function, as it includes Daily Living tests that simulate real-world functional tasks. We examined the utility of select NAB tests in predicting informant-reported IADLs in mild cognitive impairment and dementia. METHODS: The sample of 327 participants included 128 normal controls, 97 individuals with mild cognitive impairment, and 102 individuals with Alzheimer's disease dementia from the Boston University Alzheimer's Disease Center research registry. Informants completed the Lawton Brody Instrumental Activities of Daily Living Scale, and study participants were administered selected NAB tests that were complementary to the existing protocol. RESULTS: ROC curves showed strongest prediction of IADL (AUC > 0.90) for memory measures (List Learning delayed recall and Daily Living Memory delayed recall) and Daily Living Driving Scenes. At a predetermined level of specificity (95%), List Learning delayed recall (71%) and Daily Living Memory delayed recall (88%) were the most sensitive. The Daily Living Memory and Driving Scenes tests strongly predicted IADL status, and the other Daily Living tests contributed unique variance. CONCLUSIONS: NAB memory measures and Daily Living Tests may have clinical utility in detecting informant-rated functional impairment in dementia.
Authors: E Farina; R Fioravanti; R Pignatti; M Alberoni; F Mantovani; G Manzoni; L Chiavari; E Imbornone; F Villanelli; R Nemni Journal: Eur J Phys Rehabil Med Date: 2010-03 Impact factor: 2.874
Authors: S A M Sikkes; E S M de Lange-de Klerk; Y A L Pijnenburg; P Scheltens; B M J Uitdehaag Journal: J Neurol Neurosurg Psychiatry Date: 2009-01 Impact factor: 10.154
Authors: Kate de Medeiros; P Robert; S Gauthier; F Stella; A Politis; J Leoutsakos; F Taragano; J Kremer; A Brugnolo; A P Porsteinsson; Y E Geda; H Brodaty; G Gazdag; J Cummings; C Lyketsos Journal: Int Psychogeriatr Date: 2010-07-01 Impact factor: 3.878
Authors: D A Loewenstein; E Amigo; R Duara; A Guterman; D Hurwitz; N Berkowitz; F Wilkie; G Weinberg; B Black; B Gittelman Journal: J Gerontol Date: 1989-07
Authors: Amy S Zoller; Ildiko M Gaal; Christine A Royer; Joseph J Locascio; Rebecca E Amariglio; Deborah Blacker; Olivia I Okereke; Keith A Johnson; Reisa A Sperling; Dorene M Rentz; Gad A Marshall Journal: Curr Alzheimer Res Date: 2014 Impact factor: 3.498
Authors: Renée DeVivo; Lauren Zajac; Asim Mian; Anna Cervantes-Arslanian; Eric Steinberg; Michael L Alosco; Jesse Mez; Robert Stern; Ronald Killany Journal: J Int Neuropsychol Soc Date: 2019-05-27 Impact factor: 2.892
Authors: Ayal A Aizer; Nayan Lamba; Manmeet S Ahluwalia; Kenneth Aldape; Adrienne Boire; Priscilla K Brastianos; Paul D Brown; D Ross Camidge; Veronica L Chiang; Michael A Davies; Leland S Hu; Raymond Y Huang; Timothy Kaufmann; Priya Kumthekar; Keng Lam; Eudocia Q Lee; Nancy U Lin; Minesh Mehta; Michael Parsons; David A Reardon; Jason Sheehan; Riccardo Soffietti; Hussein Tawbi; Michael Weller; Patrick Y Wen Journal: Neuro Oncol Date: 2022-10-03 Impact factor: 13.029
Authors: SpiroAnthony Stathas; Victor E Alvarez; Weiming Xia; Raymond Nicks; Gaoyuan Meng; Sarah Daley; Morgan Pothast; Arsal Shah; Hunter Kelley; Camille Esnault; Robert McCormack; Erin Dixon; Lucas Fishbein; Jonathan D Cherry; Bertrand R Huber; Yorghos Tripodis; Michael L Alosco; Jesse Mez; Ann C McKee; Thor D Stein Journal: Alzheimers Dement Date: 2021-12-02 Impact factor: 16.655
Authors: Seyul Kwak; Dae Jong Oh; Yeong-Ju Jeon; Da Young Oh; Su Mi Park; Hairin Kim; Jun-Young Lee Journal: J Alzheimers Dis Date: 2022 Impact factor: 4.472